Snowden Capital Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,307
Closed -$303K 1220
2024
Q2
$303K Buy
1,307
+106
+9% +$23K 0.01% 967
2024
Q1
$259K Buy
1,201
+61
+5% +$14.3K 0.01% 1023
2023
Q4
$295K Sell
1,140
-27
-2% -$6.63K 0.01% 915
2023
Q3
$300K Sell
1,167
-424
-27% -$113K 0.01% 858
2023
Q2
$453K Buy
1,591
+39
+3% +$11.6K 0.02% 779
2023
Q1
$432K Buy
1,552
+71
+5% +$19.6K 0.02% 790
2022
Q4
$410K Buy
1,481
+437
+42% +$123K 0.02% 796
2022
Q3
$278K Sell
1,044
-63
-6% -$13.4K 0.01% 918
2022
Q2
$225K Buy
+1,107
New +$226K 0.01% 992
2022
Q1
Sell
-390
Closed -$93K 1157
2021
Q4
$93K Buy
+390
New +$100K ﹤0.01% 863
2021
Q3
Sell
-623
Closed -$216K 870
2021
Q2
$216K Sell
623
-122
-16% -$37K 0.01% 818
2021
Q1
$208K Sell
745
-1,810
-71% -$488K 0.01% 751
2020
Q4
$626K Buy
+2,555
New +$659K 0.04% 389
2019
Q1
Sell
-1,194
Closed -$359K 493
2018
Q4
$359K Sell
1,194
-22
-2% -$7.02K 0.05% 350
2018
Q3
$430K Buy
+1,216
New +$419K 0.05% 338

Other funds holding BIIB